MIMETAS

MIMETAS is a pioneer and global leader in organ-on-a-chip technology, developing predictive, human-derived 3D tissue models for drug discovery and development. Their proprietary OrganoPlate® platform enables high-throughput, physiologically relevant screening of compounds under continuous perfusion, significantly reducing reliance on animal testing while enhancing preclinical translational accuracy.